Angiotensin Converting Enzyme
Study investigated ACE I/D polymorphism in pediatric cancer patients
Published in Obesity and Diabetes Week, August 29th, 2005
According to recent research from Hungary, "Angiotensin converting enzyme (ACE) gene insertion(I)/deletion(D) polymorphism influences the outcome of a number of cardiovascular diseases. ACE I/D polymorphism was investigated by PCR in 207 pediatric cancer patients and 144 controls."
E. Bardi and colleagues of the Debrecen University of Medicine reported, "ACE I/D distribution of patients and controls was similar. The frequency of the D allele and the prevalence of the deletion (DD) genotype were significantly...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Insulin Resistance
Adiponectin prevents release of insulin resistance-inducing factors - Insulin Resistance
Alternative definitions of impaired fasting glucose developed - Insulin Resistance
Exercise-induced increase in muscle insulin sensitivity examined - Obesity and Diabetes
CART knock-out mice have glucose intolerance and increased body weight - Obesity and Diabetes
Insulin resistance reduces expression of heat shock protein 72 - Atherosclerosis
NO synthase-soluble guanylate cyclase pathway normalized by insulin - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
